Covalon Technologies Ltd. (OTCMKTS:CVALF) Short Interest Down 52.7% in November

Covalon Technologies Ltd. (OTCMKTS:CVALF) was the target of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 2,600 shares, a decline of 52.7% from the November 15th total of 5,500 shares. Based on an average trading volume of 60,700 shares, the days-to-cover ratio is presently 0.0 days.

Covalon Technologies Stock Down 4.0 %

OTCMKTS CVALF traded down $0.10 during trading hours on Friday, hitting $2.37. The company had a trading volume of 3,900 shares, compared to its average volume of 23,376. The firm has a 50 day simple moving average of $2.52 and a 200 day simple moving average of $2.07. Covalon Technologies has a 52 week low of $0.73 and a 52 week high of $3.08.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.